Boundless Bio, Inc. (BOLD) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 26.83M |
| Enterprise Value | 58M |
| P/E Ratio | -0.85 |
| PEG Ratio | -0.71 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.83 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.57 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.87 |
| Return On Equity | -0.71 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -1.25M |
| EBITDA | -56.95M |
| Net Income | -58.2M |
| Diluted EPS | -2.6 |
Balance Sheet
| Total Cash | 72.63M |
| Total Cash/Share | 3.24 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 9.48 |
| Book Value Per Share | 2.94 |
Price History
| 52-Week Change | 78.1 |
| 52-Week High | 3.16 |
| 52-Week Low | 0.96 |
| Moving Average 50 Days | 2.66 |
| Moving Average 200 Days | 1.91 |
Statistics
| Average Volume | 178,100 |
| Shares Outstanding | 22.75M |
| % Held by Institutions | 68.16 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
